Athos Capital LTD Hutchmed (China) LTD Transaction History

Athos Capital LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$17.17 - $25.95 $1.47 Million - $2.23 Million	-85,815 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$17.84 - $22.69 $491,402 - $624,996	27,545 Added 47.27%	85,815 $1.53 Million
Q2 2019 Aug 13, 2019	BUY	$22.0 - $31.78 $1.28 Million - $1.85 Million	58,270 New	58,270 $1.28 Million

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Athos Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Athos Capital LTD with notifications on news.